EXPENDITURE TRENDS
Driven by the product mix, the relative preference for newer more expensive drugs
Penetration rate of newer products in markets (e.g. statins)
Unit expenditure for older products less important
Points to market dynamics:
- Competition with generics
- Monitoring prescription